Anti-Obesity Drugs Market - Pmr Market Insight Report 2016 to 2022

Anti-Obesity Drugs Market - PMR Market Insight Report 2016 to 2022

Persistence Market Research

Anti-Obesity Drugs Market - PMR Market

Insight Report 2016 to 2022

Persistence Market Research

1

Anti-Obesity Drugs Market - PMR Market Insight Report 2016 to 2022

Persistence Market Research Released New Market Report on “Anti-Obesity Drugs

Market - PMR Market Insight Report 2016 to 2022”.

According to World Health Organization (WHO), obesity refers a disorder of

accumulation of excessive fat that can impair health. Body Mass Index (BMI) is an

index of weight for height, which is a measure for classifying obesity and

overweight. According to WHO, BMI greater than or equal to 30 is consider as an

Obese. Anti-obesity drugs refers the drugs that reduces or control the body weight

by either reducing the appetite or increasing the absorption of calories. The

fundamental treatment for obesity is to control over unhealthy diet, and regular

exercise, as although anti-obesity drugs are available in the market, their usefulness

is restricted to maintain weight rather than cure. Obesity is a risk factor for

development of several chronic diseases such as coronary heart diseases,

hypertension, metabolic disorders such as diabetes, and others. Hence, need to

control by proper medication, diet, and exercise. Bariatric surgery is an also option

for weight loss for BMI more than 40. However, lifelong changes in eating and

exercise habits are necessary after surgery.

Global anti-obesity drugs market segmented by approved drugs: buproprion and

naltrexone (Contrave), orlistat (Xenical), lorcaserin (Belviq), phentermine and

topiramate (Qsymia), and liraglutide (Saxenda). Geographically, global anti-obesity

drugs market segmented into North America, Europe, Asia Pacific, Latin America,

and rest of the World. Presently, North America holds largest share of the market

due to increasing obese population. For instance, according to Centers for Disease

Control and Prevention (CDC), more...